ASX:IBX

Imagion Biosystems Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume10.77 million shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive IBX News and Ratings via Email

Sign-up to receive the latest news and ratings for Imagion Biosystems and its competitors with MarketBeat's FREE daily newsletter.

About Imagion Biosystems

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to find and detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis. The company was incorporated in 2016 and is based in San Diego, California.

Kleos Space S.A. (KSS.AX)
July 16, 2021 | au.finance.yahoo.com

Emerge Gaming Limited (EM1.AX)
June 10, 2021 | au.finance.yahoo.com

Last Orders: Hump Day ends large caps down and small caps up
May 26, 2021 | msn.com

Imagion (ASX:IBX) share price zips 38% higher. Here’s why.
May 26, 2021 | msn.com

We're Not Very Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Rate
May 9, 2021 | finance.yahoo.com

Renergen Limited (RLT.AX)
April 21, 2021 | au.finance.yahoo.com

Imagion (ASX:IBX) share price up 1,166% in a year pursuing ‘radiation-free’ cancer tech
March 29, 2021 | msn.com

Shareholders of Imagion Biosystems (ASX:IBX) Must Be Delighted With Their 430% Total Return
February 8, 2021 | finance.yahoo.com

Imagion Biosystems Ltd.
January 17, 2021 | barrons.com

Imagion Biosystems (ASX:IBX) Is In A Good Position To Deliver On Growth Plans
November 10, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolASX:IBX
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.imagionbiosystems.com
Phone855-564-5264
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$3.17 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow3.00
Book ValueA$0.01 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.96 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Imagion Biosystems.

4.8 Community Rank

Outperform Votes
Imagion Biosystems has received 10 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Imagion Biosystems has received 4 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Imagion Biosystems has received 71.43% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Imagion Biosystems and other stocks. Vote “Outperform” if you believe IBX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IBX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Imagion Biosystems does not currently pay a dividend.
Dividend Growth
Imagion Biosystems does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Imagion Biosystems insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Imagion Biosystems (ASX:IBX) Frequently Asked Questions

What stocks does MarketBeat like better than Imagion Biosystems?

Wall Street analysts have given Imagion Biosystems a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Imagion Biosystems wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Imagion Biosystems' key executives?

Imagion Biosystems' management team includes the following people:

Mr. Robert Romeo Proulx, Exec. Chairman, Pres & CEO (Age 63, Pay $436.35k)
Mr. Geoff Hollis, CFO & Company Sec.
Dr. Marie Zhang, Vice-Pres of Research & Pre- Clinical Dev

Who are some of Imagion Biosystems' key competitors?

Some companies that are related to Imagion Biosystems include Australian Clinical Labs (ACL), BARD1 Life Sciences (BD1), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), Cryosite (CTE), dorsaVi (DVL), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Genetic Signatures (GSS), Genetic Technologies (GTG), Imagin Medical (IME), Integral Diagnostics (IDX), Lifespot Health (LSH), Med BioGene (MBGNF) and Medical Imaging (MEDD).
View all of IBX's competitors.

What other stocks do shareholders of Imagion Biosystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Imagion Biosystems investors own include Arcadia Biosciences (RKDA), Schroders (PYX), Paradigm Biopharmaceuticals (PAR), Alibaba Group (BABA) and Amani Gold (ANL).

What is Imagion Biosystems' stock symbol?

Imagion Biosystems trades on the ASX under the ticker symbol "IBX."

How much money does Imagion Biosystems make?

Imagion Biosystems has a market capitalization of $0.00 and generates $3.17 million in revenue each year.

What is Imagion Biosystems' official website?

The official website for Imagion Biosystems is www.imagionbiosystems.com.

How can I contact Imagion Biosystems?

The company can be reached via phone at 855-564-5264.

This page was last updated on 9/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.